We couldn't find that sponsor.
AD-MCI
Clinical trials for AD-MCI explained in plain language.
Never miss a new study
Get alerted when new AD-MCI trials appear
Sign up with your email to follow new studies for AD-MCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one stem cell infusion slow Alzheimer's decline?
Disease control Recruiting nowThis study tests whether adding a single infusion of human stem cells to standard antibody therapy can slow memory and thinking decline in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on antibody treatment will receive one…
Matched conditions: AD-MCI
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Zap your brain to sharper thinking? new trial tests TIS for memory loss
Symptom relief Recruiting nowThis study tests a non-invasive brain stimulation technique called temporal interference stimulation (TIS) to see if it can improve cognitive function in people with mild cognitive impairment or early Alzheimer's disease. Sixty participants will receive either real TIS or a sham …
Matched conditions: AD-MCI
Phase: NA • Sponsor: Tianjin Huanhu Hospital • Aim: Symptom relief
Last updated Jun 18, 2026 11:49 UTC